Short Communication: Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on CALGB 30610 (Alliance) / RTOG 0538
Author:
Funder
National Cancer Institute
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference9 articles.
1. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concomitantly with cisplatin and etoposide;Turrisi;N. Engl. J. Med.,1999
2. Radiation dose and fractionation for limited-stage small-cell lung cancer: survey of US radiation oncologists on practice patterns;Farrell;Clin. Lung Cancer,2019
3. 70 Gy thoracic radiotherapy is feasible concomitant with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808;Bogart;Int. J. Radiat. Oncol. Biol. Phys.,2004
4. Phase II study of accelerated high-dose radiotherapy with concomitant chemotherapy for patients with limited small-cell lung cancer: radiation Therapy Oncology Group protocol 0239;Komaki;Int. J. Radiat. Oncol. Biol. Phys.,2012
5. Rationale for phase Ⅲ trials of thoracic radiation therapy doses in limited-stage small-cell lung cancer;Bogart;Clin. Lung Cancer,2008
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Radiotherapy for Primary and Metastatic Lung Cancer;Contemporary Surgical Clerkships;2024
2. Prospective Evaluation of Limited-Stage Small Cell Lung Cancer Radiotherapy Fractionation Regimen Usage and Acute Toxicity in a Large Statewide Quality Collaborative;Practical Radiation Oncology;2023-09
3. Advancing immunotherapy in small cell lung cancer;Cancer;2023-08-21
4. High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538;Journal of Clinical Oncology;2023-05-01
5. Effect of Segmental Abutting Esophagus-Sparing Technique to Reduce Severe Esophagitis in Limited-Stage Small-Cell Lung Cancer Patients Treated with Concurrent Hypofractionated Thoracic Radiation and Chemotherapy;Cancers;2023-02-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3